12170876 · Active · incorporated 7 years, 2 months ago · London
Biotech Biotech & Life Sciences Drug Discovery Series A
A pharmaceutical drug development company focused on repurposing existing drugs for unmet medical needs, particularly in cancer treatment.
Oxilio Limited is a private limited company registered at Companies House under number 12170876, incorporated on 22 August 2019, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 53 filings for this company, including 8 funding rounds. Its most recent round closed in August 2026, raising £450k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 8 | Aug 2026 | £450k | £10.75 |
| Round 7 | Sep 2024 | £625k | £10.75 |
| Round 6 | Jul 2023 | £853k | £7.80 |
| Round 5 | Aug 2022 | £269k | £7.80 |
| Round 4 | Jan 2022 | £625k | £160.00 |
| Round 3 | Aug 2021 | £655k | £66.00 |
Showing the 6 most recent of 8 rounds.
Showing the 12 most recent of 53 filings.
See the complete cap table with every shareholder, founder tags, dilution across 13 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.